KAT2B and metabolic dysfunction-associated steatotic liver disease: P300/CBP-associated factor (PCAF)-mediated acetylation of LDHB reduces LDHB activity and inhibits lactate clearance, leading to lactate accumulation, which exacerbates lipid deposition and inflammatory responses in NAFLD and NAFLD progression (90).